Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
05/05/2025 13:44
May 5 (Reuters) - Rakovina Therapeutics Inc RKV.V: RAKOVINA THERAPEUTICS ANNOUNCES APPOINTMENT OF DR. DAVID KIDECKEL AS CHIEF FINANCIAL OFFICER RAKOVINA THERAPEUTICS INC - DAVID HYMAN STEPS DOWN AS CFO, TO REMAIN AS ADVISOR Source text: ID:nGNX7Qvcgb Further company coverage: RKV.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration